-
Signature
-
/s/ Julie Rogers, Attorney-in-Fact
-
Issuer symbol
-
RDDT
-
Transactions as of
-
20 Aug 2024
-
Net transactions value
-
-$3,874,608
-
Form type
-
4
-
Filing time
-
22 Aug 2024, 20:40:19 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RDDT |
Class A Common Stock |
Tax liability |
$2,074,976 |
-38,171 |
-2.4% |
$54.36 |
1,542,457 |
20 Aug 2024 |
Direct |
F1, F2 |
| transaction |
RDDT |
Class A Common Stock |
Options Exercise |
$0 |
+33,333 |
+2.2% |
$0.000000 |
1,575,790 |
20 Aug 2024 |
Direct |
|
| transaction |
RDDT |
Class A Common Stock |
Sale |
$574,197 |
-10,838 |
-0.69% |
$52.98 |
1,564,952 |
20 Aug 2024 |
Direct |
F3, F4 |
| transaction |
RDDT |
Class A Common Stock |
Sale |
$503,511 |
-9,326 |
-0.6% |
$53.99 |
1,555,626 |
20 Aug 2024 |
Direct |
F3, F5 |
| transaction |
RDDT |
Class A Common Stock |
Sale |
$721,925 |
-13,169 |
-0.85% |
$54.82 |
1,542,457 |
20 Aug 2024 |
Direct |
F3, F6 |
| holding |
RDDT |
Class A Common Stock |
|
|
|
|
|
161,000 |
20 Aug 2024 |
By MorMa Trust dated June 22, 2021 |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RDDT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-33,333 |
-4.2% |
$0.000000 |
753,120 |
20 Aug 2024 |
Class A Common Stock |
33,333 |
$5.35 |
Direct |
F7, F8 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: